RECURRENT THYMOMA

Clinical trials for RECURRENT THYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT THYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare thymus cancers: PT-112 trial launches

Disease control Recruiting now

This study tests a drug called PT-112 in people with thymoma or thymic cancer that has come back or worsened after standard treatment. PT-112 is designed to kill cancer cells and boost the immune system. About 53 adults will receive the drug intravenously in 28-day cycles. The ma…

Matched conditions: RECURRENT THYMOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

RECURRENT THYMOMA

Get alerted when new RECURRENT THYMOMA trials appear

New hope for rare thymus cancers: PT-112 trial launches